2024-03-28T18:04:32Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_8FC65075C2F5
2024-03-23T02:41:12Z
openaire
documents
urnserval
serval:BIB_8FC65075C2F5
A prospective, observational study of fidaxomicin use for Clostridioides difficile infection in France.
10.1177/03000605211021278
000690899800001
34162264
Guery
B.
author
Berger
P.
author
Gauzit
R.
author
Gourdon
M.
author
Barbut
F.
author
DAFNE study group
contributor
Dafne Study Group
contributor
Bémer
P.
author
Bessède
E.
author
Camou
F.
author
Cattoir
V.
author
Couzigou
C.
author
Descamps
D.
author
Dinh
A.
author
Laurans
C.
author
Lavigne
J.P.
author
Lechiche
C.
author
Leflon-Guibout
V.
author
Le Monnier
A.
author
Levast
M.
author
Mootien
J.Y.
author
N'Guyen
Y.
author
Piroth
L.
author
Prazuck
T.
author
Rogeaux
O.
author
Roux
A.L.
author
Vachée
A.
author
Vernet Garnier
V.
author
Wallet
F.
author
article
2021-06
The Journal of international medical research
1473-2300
0300-0605
journal
49
6
3000605211021278
Aminoglycosides/adverse effects
Anti-Bacterial Agents/adverse effects
Clostridioides
Clostridioides difficile
Clostridium Infections/drug therapy
Fidaxomicin
France
Humans
Prospective Studies
Vancomycin
Clostridioides (Clostridium) difficile
antibiotic usage
clinical
fidaxomicin
infection
real-world setting
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Multicenter Study ; Observational Study
Publication Status: ppublish
https://serval.unil.ch/notice/serval:BIB_8FC65075C2F5
https://serval.unil.ch/resource/serval:BIB_8FC65075C2F5.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8FC65075C2F53
Creative Commons : Attribution-NonCommercial 4.0 International